Plasticity of alpha 2-adrenergic spinal antinociception following nerve injury: Selective, bidirectional interaction with the delta opioid receptor

• Published in: Brain research 2015-01, Vol.1594, p.190-203
• Main Authors: Aira, Zigor, Barrenetxea, Teresa, Buesa, Itsaso, Azkue, Jon Jatsu
• Format: Article
• Language: English
• ISSN: 0006-8993
• DOI: 10.1016/j.brainres.2014.11.009

Interactions of opioid receptors with other receptor families can be made use of to improve analgesia and reduce adverse effects of opioid analgesics. We investigated interactions of the alpha 2-adrenergic receptor ( alpha 2AR) with opioid receptors of the mu (MOR) and delta (DOR) types in the spinal dorsal horn in an animal model of neuropathic pain induced by spinal nerve ligation. Nine days after nerve injury, immunoreactivity for the alpha 2AR subtype A ( alpha 2AAR) was increased both in tissue homogenates and at pre- and post-synaptic sites in transverse sections. The efficacy of spinally administered alpha 2AAR agonist guanfacine at reducing C-fiber-evoked field potentials was increased in nerve-ligated rats. This reducing effect was impaired by simultaneous administration of DOR antagonist naltrindole, but not MOR antagonist CTOP, suggesting that concurrent DOR activation was required for alpha 2AAR-mediated inhibition. While DOR agonist deltorphin II and MOR agonist DAMGO both effectively depressed C-fiber-evoked spinal field potentials, DOR- but not MOR-mediated depression was enhanced by subclinical guanfacine. In conscious, nerve-ligated rats, chronically administered deltorphin II produced stable thermal and mechanical antinociception over the 9 following days after nerve injury without apparent signs of habituation. Such an effect was dramatically enhanced by co-administration of a low dose of guanfacine, which reversed thermal and mechanical thresholds to levels near those prior to injury. The results suggest that spinal, alpha 2AAR-mediated antinociception is increased after nerve injury and based on DOR co-activation. We demonstrate in vivo that alpha 2AAR/DOR interaction can be exploited to provide effective behavioral antinociception during neuropathic pain.